Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Leases (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Leases for 2 consecutive years, with $13.2 million as the latest value for Q3 2023.

  • On a quarterly basis, Leases rose 85.32% to $13.2 million in Q3 2023 year-over-year; TTM through Sep 2023 was $13.2 million, a 85.32% increase, with the full-year FY2022 number at $5.6 million, changed N/A from a year prior.
  • Leases was $13.2 million for Q3 2023 at LENZ Therapeutics, down from $15.8 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $15.8 million in Q2 2023 to a low of $4.0 million in Q1 2023.